← All organizations
Highest phase reached
Phase 2
Timeline
1990s
- Jan 1, 1994
AkzoNobel— Founded
- Jan 1, 1994
Akzo— Acquired
- Jun 1, 1994
Nobel Industries— Acquired
- Jan 1, 1999
Kanebo— Acquired
2000s
- Jan 1, 2005
Diosynth— Acquired
- Jan 1, 2008
Imperial Chemical Industries— Acquired
2010s
- Jan 15, 2016
irbesartan— Marketing Organization
Drugs by trial phase (3 distinct, 7 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (0 own, 1 via acquisition)
Other trials (0 own, 1 via acquisition)
Marketed drugs (2)
Subsidiaries (5 direct, 21 total across the full acquisition tree)
- Akzo
- Diosynth
- Imperial Chemical Industries
- Kanebo
- Nobel Industries
- Algemene Kunstzijde Unie L2
- Atlas Chemical Industries L2
- British Dyestuffs Corporation L2
- Brunner Mond L2
- Elektrokemiska Aktiebolaget L2
- KemaNobel L2
- Nederlandsche Cocainefabriek L2
- Nobel Explosives L2
- United Alkali Company L2
- Yamashiro Pharmaceuticals Company L2
- Barnängen Tekniska Fabrik AB L3
- Casco L3
- Liljeholmens Stearinfabriks L3
- Nederlandse Kunstzijdefabriek L3
- Stuart Pharmaceuticals L3
- Vereinigte Glanzstoff Fabrike L3
Recent trials (1)
- NCT00386074CollaboratorPhase 2May 1, 2004
Details
- Founded
- Amsterdam, NL Jan 1, 1994
- Last known activity
- Jan 15, 2016